-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NERe6J0k2C5h7J3PQF5L0iOCIEVEgQm56YN3TslKBRICJePMI7XaXS2jF5Z2TUO0 CIW1rc2w+0j6+Ia44hs4PA== 0000732485-03-000005.txt : 20030702 0000732485-03-000005.hdr.sgml : 20030702 20030701195222 ACCESSION NUMBER: 0000732485-03-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20030702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COONEY CHARLES L CENTRAL INDEX KEY: 0001021048 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 03769354 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 coo38.xml X0101 4 2003-06-30 0 0000732485 GENZYME CORP GENZ 0001021048 COONEY CHARLES L 1 0 0 0 Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 5584 0 D 0 D Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 37 0 D 0 I By Son Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 14 0 D 0 I By Spouse Genzyme General common stock (GENZ) 2003-06-30 4 J 0 274 0 A 10576 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 78 0 A 10654 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 1 0 A 2695 I By Son Genzyme General common stock (GENZ) 2003-06-30 4 J 0 1 0 A 2696 I By Son Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 1397 0 D 0 D Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 34 0 D 0 I By Son Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 12 0 D 0 I By Spouse Biosurgery DOP stock option (right to buy) 14.17 2003-06-30 4 J 0 1676 0 D 1994-12-16 2004-12-16 Genzyme Biosurgery common stock (GZBX) 1676 0 D Biosurgery DOP stock option (right to buy) 36.55 2003-06-30 4 J 0 2483 0 D 1999-05-26 2006-05-16 Genzyme Biosurgery common stock (GZBX) 2483 0 D Biosurgery DOP stock option (right to buy) 6.25 2003-06-30 4 J 0 4022 0 D 2002-05-26 2009-05-26 Genzyme Biosurgery common stock (GZBX) 4022 0 D Biosurgery DOP stock option (right to buy) 11.04 2003-06-30 4 J 0 7272 0 D 2000-05-25 2009-08-26 Genzyme Biosurgery common stock (GZBX) 7272 0 D Biosurgery DOP stock option (right to buy) 6.69 2003-06-30 4 J 0 8000 0 D 2001-05-31 2011-02-09 Genzyme Biosurgery common stock (GZBX) 8000 0 D Biosurgery DOP stock option (right to buy) 6.26 2003-06-30 4 J 0 2000 0 D 2002-05-31 2011-05-31 Genzyme Biosurgery common stock (GZBX) 2000 0 D Biosurgery DOP stock option (right to buy) 4.24 2003-06-30 4 J 0 18000 0 D 2003-05-30 2012-05-30 Genzyme Biosurgery common stock (GZBX) 18000 0 D Genzyme General DOP stock option (right to buy) 286.56 2003-06-30 4 J 0 82 0 A 1994-12-16 2004-12-16 Genzyme General common stock (GENZ) 82 82 D Genzyme General DOP stock option (right to buy) 739.13 2003-06-30 4 J 0 122 0 A 1997-05-29 2006-05-16 Genzyme General common stock (GENZ) 122 122 D Genzyme General DOP stock option (right to buy) 124.69 2003-06-30 4 J 0 151 0 A 1997-05-18 2007-06-18 Genzyme General common stock (GENZ) 151 151 D Genzyme General DOP stock option (right to buy) 62.35 2003-06-30 4 J 0 673 0 A 2000-05-25 2009-05-26 Genzyme General common stock (GENZ) 673 673 D Genzyme General DOP stock option (right to buy) 126.39 2003-06-30 4 J 0 198 0 A 2000-05-26 2009-05-26 Genzyme General common stock (GENZ) 198 198 D Genzyme General DOP stock option (right to buy) 223.26 2003-06-30 4 J 0 359 0 A 2000-05-25 2009-08-26 Genzyme General common stock (GENZ) 359 359 D Genzyme General DOP stock option (right to buy) 135.29 2003-06-30 4 J 0 395 0 A 2001-05-31 2011-02-09 Genzyme General common stock (GENZ) 395 395 D Genzyme General DOP stock option (right to buy) 126.60 2003-06-30 4 J 0 98 0 A 2002-05-31 2011-05-31 Genzyme General common stock (GENZ) 98 98 D Genzyme General DOP stock option (right to buy) 274.32 2003-06-30 4 J 0 112 0 A 2002-05-31 2011-05-31 Genzyme General common stock (GENZ) 112 112 D Genzyme General DOP stock option (right to buy) 85.75 2003-06-30 4 J 0 890 0 A 2003-05-30 2012-05-30 Genzyme General common stock (GENZ) 890 890 D Genzyme General DOP stock option (right to buy) 41.51 2003-06-30 4 J 0 1010 0 A 2003-05-30 2012-05-30 Genzyme General common stock (GENZ) 1010 1010 D Molecular Oncology DOP stock option (right to buy) 7.00 2003-06-30 4 J 0 2700 0 D 1997-06-18 2007-06-18 Genzyme Molecular Oncology common stock (GZMO) 2700 0 D Molecular Oncology DOP stock option (right to buy) 3.50 2003-06-30 4 J 0 12000 0 D 2000-05-30 2009-05-26 Genzyme Molecular Oncology common stock (GZMO) 12000 0 D Molecular Oncology DOP stock option (right to buy) 15.40 2003-06-30 4 J 0 2000 0 D 2002-05-30 2011-05-31 Genzyme Molecular Oncology common stock (GZMO) 2000 0 D Molecular Oncology DOP stock option (right to buy) 2.33 2003-06-30 4 J 0 18000 0 D 2003-05-30 2012-05-30 Genzyme Molecular Oncology common stock (GZMO) 18000 0 D On June 30, 2003 all outstanding shares of Genzyme Biosurgery and Genzyme Molecular stock were exchanged for shares of Genzyme General Stock. Genzyme Biosurgery shareholders received .04914 of a share of Genzyme General stock for each Biosurgery share and Genzyme Molecular Oncology shareholders received .05653 of a share of Genzyme General stock for each Molecular Oncology share. On June 30, 2003 in relation to the elimination of Genzyme's tracking stock structure, all stock options of Genzyme Biosurgery and Genzyme Molecular were exchanged for stock options of Genzyme General. The exchange ratio was based on the closing prices of all three stocks on 6/30/03. Genzyme Biosurgery options were exchanged at a rate of .04945 and Genzyme Molecular Oncology options were exchanged at a rate of .05614. Options vest in 1/3 annual increments on the dates of the next three annual meetings of shareholders following the original date of grant. Options vest in 1/3 annual increments for 3 years beginning 5/25/00. Options vest in 50% increments on May 31,2001 and May 31, 2002. By: Susan P. Cogswell, Attorney-in-Fact 2003-07-01 -----END PRIVACY-ENHANCED MESSAGE-----